Market News & Trends
Dendreon Corporation Sells Royalty Rights for $125 Million
Dendreon Corporation recently announced it has agreed to sell for $125 million in cash its royalty interest related to intellectual property licensed to Schering-Plough Ltd.…
Innovus Completes Reverse Merger Agreement With North Horizon
Innovus Pharmaceuticals, Inc., recently announced that FasTrack Pharmaceuticals, Inc. completed its previously announced merger agreement with North Horizon Inc., subsequent to which FasTrack was acquired…
Pharmacyclics Could Get Almost $1 Billion in Licensing Deal
Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, recently announced it has executed an agreement with Pharmacyclics, Inc. to jointly…
12/6/2011
Nanion's SyncroPatch 96 Convinces Big Pharma Automated Patch Clamp Users Nanion's ion channel screening platform, the SyncroPatch 96, has been well received within the pharmaceutical…
Ampio Pharmaceuticals Announces Agreement to Acquire Key Delivery Technology
Ampio Pharmaceuticals, Inc. recently announced it has signed an agreement to acquire certain rights relating to a patented orally disintegrating tablet (ODT) drug delivery technology…
Heparinex Receives $1.6-Million Award to Enable CMC for Proprietary Delivery Technology
Heparinex, LLC recently announced the company has received a $1.6-million fund endowment from the Economic Development Generating Excellence program (EDGE). Heparinex and the University of…
MacroGenics Strikes Deal With Servier, Potentially Worth Up to $450 Million
MacroGenics, Inc. and Servier recently announced they have entered into an option for a license agreement for the development and commercialization of MGA271, MacroGenics' proprietary…
Momenta Buys Assets From Virdante for Up to $51.5 Million
Momenta Pharmaceuticals, Inc. recently announced it has signed an agreement to acquire the Sialic Switch assets of Virdante Pharmaceuticals, Inc., including intellectual property and cell…
Nanion's SyncroPatch 96 Convinces Big Pharma Automated Patch Clamp Users
Nanion's ion channel screening platform, the SyncroPatch 96, has been well received within the pharmaceutical industry during the past 12 months. Experienced automated patch clamp…
Tibotec Enters Agreement With BMS for Phase II Combination Study
Bristol-Myers Squibb Company recently announced it has entered into a clinical collaboration agreement with Tibotec Pharmaceuticals, one of the Janssen Pharmaceutical Companies, to evaluate the…
Gilead Sciences to Acquire Pharmasset for $11 Billion
Gilead Sciences, Inc. and Pharmasset, Inc. recently announced the companies have signed a definitive agreement under which Gilead will acquire Pharmasset for $137 per share…
Isis to Receive $14 Million for Its Excaliard Acquisition
Isis Pharmaceuticals, Inc. recently announced it will receive up to $14 million from Pfizer Inc. for its equity ownership of Excaliard Pharmaceuticals, Inc. from Pfizer's…
Medicis Buys Graceway Pharmaceuticals in $455 Million Bankruptcy Sale
Medicis recently announced it was the successful bidder at a bankruptcy auction conducted by Graceway Pharmaceuticals, LLC for substantially all of the outstanding US and…
Valeant Pharmaceuticals Agrees to Acquire iNova Pharmaceuticals
Valeant Pharmaceuticals International, Inc. recently announced it has signed an agreement to acquire iNova, a private pharmaceutical group that sells and distributes a range of…
11/29/2011
Biocon Launches Haselmeier's Insulin Pen in India Haselmeier recently announced that Biocon, one of Asia's premier biotechnology companies, has launched INSUPen in India. Under the…
Aileron Therapeutics, Roche Expand $1.1-Billion Drug Collaboration
Aileron Therapeutics recently announced that Roche will initiate a new program to expand its collaboration with Aileron to discover, develop, and commercialize Stapled Peptide drugs.…
Biocon Launches Haselmeier's Insulin Pen in India
Haselmeier recently announced that Biocon, one of Asia's premier biotechnology companies, has launched INSUPen in India. Under the terms of the agreement between the two…
11/22/2011
Apricus Biosciences Announces NexACT Partner Has Completed pre-IND Meeting Apricus Biosciences, Inc. recently announced its NexACT out-licensing partner, Exodos Life Science Limited Partnership, has completed…
Apricus Biosciences Announces NexACT Partner Has Completed pre-IND Meeting
Apricus Biosciences, Inc. recently announced its NexACT out-licensing partner, Exodos Life Science Limited Partnership, has completed a successful pre-IND meeting with the US FDA regarding…
Bend Research Signs Technology Licensing Agreement With Merck
Bend Research Inc., a leading independent drug formulation development and manufacturing company, recently announced it has entered into a licensing agreement with Merck, through a…
